Western Pacific Wealth Management’s Gilead Sciences GILD Stock Holding History

Western Pacific Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,002	Closed	-$73.4K	–	256
2024 Q1	$73.4K	Sell	1,002 -20	-2%	-$1.54K	0.05%	121
2023 Q4	$82.8K	Buy	1,022 +356	+53%	+$27.7K	0.06%	108
2023 Q3	$49.9K	Buy	666 +109	+20%	+$8.38K	0.04%	137
2023 Q2	$42.9K	Hold	557	–	–	0.03%	152
2023 Q1	$46.2K	Buy	557 +525	+1,641%	+$43.5K	0.04%	151
2022 Q4	$2.75K	Buy	+32	New	+$2.53K	﹤0.01%	257

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Western Pacific Wealth Management's GILD Position: Q2 2024 in Review

Western Pacific Wealth Management sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 1,002 shares — an estimated $73.4K sold.

Western Pacific Wealth Management first reported a position in GILD in Q4 2022 and held it in 6 quarters. The position peaked at $82.8K in Q4 2023. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

Western Pacific Wealth Management reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
Western Pacific Wealth Management sold 1,002 Gilead Sciences shares in Q2 2024, an estimated $73.4K.
Western Pacific Wealth Management first reported a position in Gilead Sciences in Q4 2022 and held it in 6 quarters.
Western Pacific Wealth Management's Gilead Sciences position peaked at $82.8K in Q4 2023.
1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Western Pacific Wealth Management's 13F filing for Q2 2024, filed 14 Aug 2024.